Complexation hydrogels for stabilization of peptidic HIV-1 virucides

P. L. Kubinski, A. M. Lowman, P. L. Kubinski, C. Duffy, Kantharaju, M. R. Contarino, I. Chaiken

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Human immunodeficiency virus 1 (HIV-1), the causative agent of acquired immune deficiency syndrome (AIDS), is a critical health priority. Although many therapies have been developed to slow the progression of AIDS, there are still no treatments available that can prevent or completely remove the infection. Recently, a highly potent, peptide triazole (PT) class of HIV-1 entry inhibitors has been identified that holds great promise for preventing HIV transmission. The purpose of this work is to enhance the in vivo stability of peptide triazoles by encapsulation in a pH-responsive hydrogel, composed of poly(methacrylic acid-g-ethylene glycol). Hydrogel loading and release of PT compositions are studied, and the stability of encapsulated PTs in enzymatic solutions is investigated.

Original languageEnglish (US)
Title of host publication2012 38th Annual Northeast Bioengineering Conference, NEBEC 2012
Pages422-423
Number of pages2
DOIs
StatePublished - 2012
Externally publishedYes
Event38th Annual Northeast Bioengineering Conference, NEBEC 2012 - Philadelphia, PA, United States
Duration: Mar 16 2012Mar 18 2012

Publication series

Name2012 38th Annual Northeast Bioengineering Conference, NEBEC 2012

Other

Other38th Annual Northeast Bioengineering Conference, NEBEC 2012
Country/TerritoryUnited States
CityPhiladelphia, PA
Period3/16/123/18/12

All Science Journal Classification (ASJC) codes

  • Bioengineering

Fingerprint

Dive into the research topics of 'Complexation hydrogels for stabilization of peptidic HIV-1 virucides'. Together they form a unique fingerprint.

Cite this